טוען...
Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database
BRAF mutations are relatively common in many cancers, particularly melanoma, colorectal cancer, and thyroid cancer and to a lesser extent in lung cancer. These mutations can be targeted by BRAF and MEK inhibitors, which exhibit good clinical activity. There are conflicting reports of the various rel...
שמור ב:
| הוצא לאור ב: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797994/ https://ncbi.nlm.nih.gov/pubmed/33019809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370220959657 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|